IRVINE, Calif., Jan. 11, 2018 /PRNewswire/ -- Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest ...
more»